Dr. Michael Brandon Freeman, MD

Dr. Freeman practices at Bakersfield Specialists Surgical Center in Bakersfield, California.

Dr. Freeman's NPI, 1770789448, was assigned on June 21, 2007. Dr. Freeman graduated from UNMC in 2001. Dr. Freeman's California license number on file is A103459.

Dr. Freeman's primary practice is Bakersfield Specialists Surgical Center, at 4500 Morning Drive, Suite 102, Bakersfield, CA 93306. The practice phone is (661) 437-4140.

Dr. Freeman's primary practice is Bakersfield Specialists Surgical Center in Bakersfield, California. Dr. Freeman is also affiliated with Adventist Health Bakersfield. The medical group on file is Adventist Health Physicians Network. Dmand AI also links Dr. Freeman to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Freeman practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Freeman's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Freeman is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Freeman's licenses on file in 4 states: California, Nebraska, Rhode Island and Texas.

Dmand AI lists breast reconstruction, cancerous skin growth removal, head wound and minor head injury among the conditions Dr. Freeman treats.

CMS data shows 76 Medicare services from Dr. Freeman across 2 procedure codes in 2024, all of them office visits, for 79 Medicare patients. Medicare paid $5,518 for them.

CMS counts 79 Medicare patients who saw Dr. Freeman in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Freeman's median patient age at 52, with 77% women.

In 2024, Dr. Freeman wrote 23 Medicare Part D claims for 14 patients. 96% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $94 in total drug cost. In 2023, CMS named 27 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Freeman for performance year 2024, reported through an alternative payment model (APM). Dr. Freeman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 21 procedures of mastectomy by Dr. Freeman, more than 79% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 23 papers to Dr. Freeman, published from 2004 to 2014. The most frequent topics are Stents, Blood Vessel Prosthesis Implantation and Aortic Aneurysm, Abdominal. Dr. Freeman has published most often in J Vasc Surg. Dr. Freeman's most frequent co-authors are Mitchell H. Goldman, MD, Michael Benton Freeman, MD and David C. Cassada, MD.

CMS Open Payments shows 303 general payments to Dr. Freeman from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. Allergan Inc. paid the most, $1,984. It also lists 209 research payments totaling $136,171 from 2018 to 2025.

Dr. Freeman graduated from UNMC in 2001.

Dr. Freeman is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.